| abstract |
The compositions and methods relate to organic molecules that bind to these proteins at the copper transport interface of human Atox1 and CCS. This binding suppresses copper transport, thereby inhibiting cancer cell proliferation and tumor growth. In addition to serving as an effective cancer treatment, these organic molecules block cellular copper uptake, treat copper metabolism disorders such as Wilson's disease characterized by copper overload, and as wound healing. Can be used. |